Sarantis Worldwide


Visit our group site

Sarantis Group| English

Or choose a location

Completion of the share buyback program

23 MAY 2018

The company GR. SARANTIS S.A. informs the investment community of the completion of its share buyback program which was approved, in accordance with the provisions of article 16 of C.L. 2190/1920, as in force, by the extraordinary General Meeting of June 9th 2016.

Through this program the Company was given approval to purchase up to 10% of the company's share capital, with a maximum buy back price at fifteen euros (15.00 €) per share and a lowest at one euro and fifty five cents (1.55 €), within a 2-year period, that is up to May 17th 2018.

During the aforementioned program and in effect of the article 5 of the 596/2014 Regulation of the European Parliament and of the Council, the Company has acquired 1,365,800 common shares in total, corresponding to 3.91% of its share capital at an average price of 9.17 euro per share having a total cost of 12,528,913 euro.

Completion of the share buyback program (406.0KB)

Sarantis Group: Pharmacy Company of the Year and Nine Awards for Lanes, Clinéa & PIC at the Best in Pharmacy Awards 2024

Sarantis Group has once again confirmed its strong presence in the pharmaceutical market by winning nine significant awards at the Best in Pharmacy Awards 2024. Organized for the 7th consecutive year in Greece by BOUSSIAS Events, these awards recognize outstanding performance in pharmacy products, creativity, and strategic marketing practices that promote these products in the market.
More
Change cookies consent Revoke cookies consent